Telepathy in Psychedelic Therapy

"May 10, 2026 Psymposia board member Dr. Neşe Devenot’s presentation at the Ohio State University “Religion and Psychedelics” conference, recorded March 28, 2026. In this talk, Dr. Devenot presents their research on the reliance on unscientific telepathic attunement in many popular schools of psychedelic therapy."
#Psymposia and #Neşe #osu #psychedelic #therapy #unregulated #cult #maps #ethics #informedconsent
https://youtu.be/_Iawxp2wKMQ?si=Yxv-A-ckxuDDYuyn

"#Psychedelics are the next front in #BigTech's dystopia. #Psymposia developed this primer for leftists in response to Donald #Trump‘s April 18 #ExecutiveOrder, which accelerates review of psychedelic drugs deemed “#BreakthroughTherapies” and makes Schedule 1 drugs more accessible under #RighttoTry laws.

This announcement made a splash in psychedelic media, where praise for the Trump administration mixes with false claims about an “end to prohibition.”

This move represents a crystallization of far-right interest in the psychedelic industry and a step towards oligarch monopolization of psychedelic medicine by figures including Peter Thiel and Musk lieutenant Antonio Gracias. We end by discussing the risks of elite control over drugs that have been developed to shift identity — especially when those elites are simultaneously devoted to killing the so-called "woke mind virus" and remaking the global order in Palantir's image."

https://m.youtube.com/watch?v=VI2GMUDT-ig

From where I stand, the linked article below looks like an opportunistic partisan move. In my view, people from both sides of the dispute (#MAPS AND #Psymposia) managed to slow down the progress of #psychedelicMedicine (maybe for good).
But I agree with Ms. Devenot that, specially by tagging #Left on the title, it is a "transparently partisan attack" that "politicized whistleblowers to appeal to the #Trump administration on behalf of a #pharmaceuticalcompany." (#Lykos)

https://www.nytimes.com/2025/02/04/health/fda-mdma-psychedelic-therapy-psymposia.html?unlocked_article_code=1.vE4.fOfO.GlkdCIj0dlvk&smid=nytcore-ios-share&referringSource=articleShare